Clin2
NCT07594496Likely a fitEnrolling by invitation

Cannabis Withdrawal in Blood Cancer Patients During Stem Cell Transplant

Hematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm

Part of Blood & lymphatic, Cancer, Mental health clinical trials.

This study looks at whether patients with blood cancers who use cannabis experience withdrawal symptoms when hospitalized for stem cell transplant or CAR-T therapy (a type of immunotherapy). Understanding these symptoms could help doctors better support patients during treatment.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
300 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are an adult (18 or older)
  • You are admitted to the hospital for bone marrow/stem cell transplant or CAR-T cell therapy
  • You are able to understand the study and provide informed consent (or have a legal representative who can)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07565974Not yet recruiting· Phase 2
Cannabis for improving sleep in people with cancer

This study is testing whether taking a cannabis compound (THC with or without CBD) can improve sleep quality for people with solid organ cancers. If you have moderate-to-severe insomnia and are interested in a non-drug option, you might qualify.

Rochester, Minnesota
NCT07658677Not yet recruiting· Phase 1/Phase 2
Cannabis gummy for improving sleep in cancer patients

This study tests whether a cannabis gummy can improve sleep and quality of life for people with cancer. You would take a gummy nightly, wear a fitness tracker, and answer short surveys about your sleep and well-being.

Columbus, Ohio
NCT06418204Recruiting
Cannabis use among cancer patients in community clinics

This study looks at how cancer patients use cannabis (marijuana) and cannabis products to manage symptoms during chemotherapy or immunotherapy. The goal is to learn about the benefits and risks so doctors can better guide patients.

Fairbanks, Alaska
NCT06206941Recruiting
Cannabis for pain in cancer immunotherapy patients

This study looks at how cannabis affects symptoms in cancer patients who are getting immunotherapy. It may help understand if cannabis can improve pain and quality of life during treatment.

Portland, Oregon
NCT07089225Not yet recruiting
Using a cannabis journal app to track symptoms in cancer care

This study asks cancer patients who use cannabis to track their symptoms and cannabis use with a smartphone app. The goal is to learn how cannabis affects symptom management during cancer treatment.

NCT07459920Not yet recruiting· Phase 2
Cannabis extract for cancer-related symptoms

This trial tests whether a cannabis extract can help reduce symptoms like pain, nausea, anxiety, and poor appetite in people with advanced cancer. If you are already on strong pain medication and struggling with these symptoms, this study aims to see if adding cannabis improves your quality of life.

Naples

Hear when a new Hematopoietic and Lymphatic System Neoplasm trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.